Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions Adds: Clevertech Updates: Rocket Lab, Martin Marietta Materials, Zymeworks, Matador Resources
June 29 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:
** Rocket Lab <RKLB.O> struck an $8 billion deal to acquire satellite communications provider Iridium Communications <IRDM.O>, betting that owning everything from rockets to satellite networks will define the next generation of space companies. nL6N4310O4
** Matador Resources <MTDR.N> said its midstream joint venture San Mateo Midstream will acquire the operating units of Cardinal Midstream Partners for $752 million in cash, expanding its natural gas gathering and processing footprint in the Delaware Basin. nL4N4310RJ
** Private equity group CVC Capital Partners <CVC.AS> has agreed to acquire Italian industrial automation company Clevertech from the Reggiani family, it said. nL6N4310PK
** CVC also entered into an agreement to acquire Italian dessert ingredients maker Irca from Advent International. nL6N4310JA
** Martin Marietta Materials <MLM.N> said it would merge with limestone supplier Lhoist North America in a cash-and-stock deal worth $13.5 billion, as the building material firm looks to tap growing demand for lime products. nL4N4310UP
** Zymeworks <ZYME.O> said it will acquire Theravance Biopharma <TBPH.O> for $929 million in cash, marking the oncology-focused drugmaker's entry into the highly competitive respiratory disease segment. nL4N4310R7
** Turkish construction firm Libco Insaat has signed a deal to buy a 32% stake in Turkish conglomerate Tekfen Holding TKFEN.IS, less than a month after Turkey's military pension fund Oyak began talks to buy a separate stake. nL6N4310J0
** British private equity group Bridgepoint BPTB.L has agreed to buy U.S.-based Kayne Anderson's real estate business in a deal valued at about $1.4 billion, it said, driving its shares up more than 10%. nL4N4310E7
** Ipsen IPN.PA will buy U.S.-based Kartos Therapeutics for $450 million to expand its oncology pipeline with a late-stage blood cancer treatment, the French biotech company said. nL6N4310GH
** Swedish care provider Ambea AMBEA.ST said it had made a recommended public offer for peer Humana HUMAN.ST, valuing the company at about 2.96 billion Swedish crowns ($304.13 million). nL8N431050
** U.S. pipeline operator Williams WMB.N is in advanced talks to acquire rival natural gas pipeline operator Momentum Midstream for about $5.5 billion, Bloomberg News reported on Sunday, citing people familiar with the matter. nL6N4300AA
** Finnish energy company Fortum FORTUM.HE has agreed terms for a recommended, conditional voluntary cash tender offer to buy all shares in Norway's Elmera Group ELMRA.OL, worth about NOK 5.1 billion ($513.55 million), topping a rival approach disclosed last week. nL6N4310I7
** Investment vehicles managed by Sixth Street have agreed to acquire a majority stake in Monument Re, a Bermuda-based reinsurer and consolidator of European life insurance portfolios. nL6N4310JN
** Turkish construction firm Libco Insaat has signed a deal to buy a 32% stake in Turkish conglomerate Tekfen Holding TKFEN.IS. nL6N4310J0
(Compiled by Rajarshi Roy and Nandan Mandayam in Bengaluru)
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions